SEC Form D · Amendment · filed February 22, 2024
OcuTerra Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
William H. Koster · Boston, MADirectorNick Dicarlo · Bethlehem, PADirectorBruce H. Failing · Boston, MADirectorRobin H. Steele · Boston, MADirectorErik Stevens · Napa, CAExecBrenton S. Saunders · Boston, MADirectorNickolay E. Bochilo · Greensboro, NCDirectorDavid J. Tanzer · Boston, MAExecWilliam S. Steinkrauss · Boston, MAExecCindy E. Clare · Greensboro, NCDirectorBruce H. Failing · Boston, MADirectorManager of the Issuer Seven Hills Capital, LLC · Nashville, TNExecRobert H. Ruffolo · Boston, MADirectorWilliam S. Steinkrauss · Boston, MAExecBarbara H. Ryan · Boston, MADirectorKerrie Brady · Boston, MAExec · DirectorMatthew Joslin · Laguna Beach, CAExec · DirectorBarbara H. Ryan · Boston, MADirectorKerrie Brady · Boston, MAExec · DirectorCraig F. Farber · New York, NYExecDavid J. Tanzer · Boston, MAExecWilliam H. Koster · Boston, MADirectorE. D. Bell · Greensboro, NCDirectorD. S. Edwards · Boston, MAExecDavid West · Bethlehem, PADirectorRobin H. Steele · Boston, MADirectorD. S. Edwards · Boston, MAExecBrenton S. Saunders · Boston, MADirectorCristie Kerr · Napa, CADirectorRobert H. Ruffolo · Boston, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗